Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C6HM
|
|||
Former ID |
DIB003855
|
|||
Drug Name |
Cebaracetam
|
|||
Synonyms |
CGS-25248; ZY-15119
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Discontinued in Phase 2 | [1] | |
Company |
Novartis AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H18ClN3O3
|
|||
Canonical SMILES |
C1CN(CC(=O)N1)C(=O)CN2CC(CC2=O)C3=CC=C(C=C3)Cl
|
|||
InChI |
1S/C16H18ClN3O3/c17-13-3-1-11(2-4-13)12-7-15(22)20(8-12)10-16(23)19-6-5-18-14(21)9-19/h1-4,12H,5-10H2,(H,18,21)
|
|||
InChIKey |
QPKMIYNBZGPJAR-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 113957-09-8
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001741) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.